Qasim Rizvi, KSQ Therapeutics CEO
KSQ Therapeutics sells early-stage targeted therapies to Japan's Ono
As it moves deeper into a Phase I trial of its lead program, KSQ Therapeutics is selling a slate of earlier-stage oncology programs in exchange …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
